Clinical Trial Update May/June 2026 - Summary - MDSpire
Clinical Guidelines
From the Journals
Conference News

Clinical Trial Update May/June 2026

Access Retinal Physician's listing of all active clinical trials in AMD, DME, RVO, and uveitis.

  • May 1, 2026

  • 40 min

Share

A comprehensive overview of active clinical trials focused on age-related macular degeneration (AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and uveitis has emerged, showcasing various treatment innovations. These include studies involving both pharmaceutical interventions such as ABF-101, BS01, and different gene therapies, as well as novel approaches like probiotics and stem cell applications. These trials aim to evaluate safety, efficacy, and tolerability among diverse patient populations, emphasizing the need for continued research in retinal diseases.

Original Source(s)

Clinical Trial Update May/June 2026

  • May 1, 2026

Related Content

AI Supports Glaucoma Surgical Planning

Predictive models identify high-risk patients and support earlier treatment decisions.

Radical Transparency: The Future of Ophthalmic Practice

As patient expectations and legal scrutiny rise, ophthalmology must strive to measure and document every step of care

CXL Outcomes Consistent Across Populations

Ethnicity and age show limited impact on cross-linking outcomes for keratoconus

  • April 16, 2026

  • 3 min